Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.20
Bid: 5.00
Ask: 5.40
Change: 0.09 (1.75%)
Spread: 0.40 (8.00%)
Open: 5.15
High: 5.24
Low: 5.15
Prev. Close: 5.15
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Directa Plus wins deal; Greatland loss widens

Fri, 28th Oct 2022 11:33

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Allergy Therapeutics PLC, up 4.4% at 17.75 pence, 12-month range 15.25p-38.50p. The biotechnology firm says it will resume production at Freeman facility in Worthing, England on November 14. This follows a short-term voluntary pause as it reviewed its operating processes. It does, however, warn revenue will be around 13% to 18% lower than market expectations of around GBP80 million, for the current financial year ending on June 30, as the pause occurred during a period of peak production. This suggests revenue of about GBP66 million to GBP70 million in financial 2023. Partially compensating, business expenses were reduced by GBP3 million by the shutdown.

----------

Directa Plus, up 2.3% at 90.00 pence, 12-month range 74.00p-178.00p. The graphene product maker signs an exclusive supply agreement in Latin America, worth around EUR1 million. The agreement with Colombian ballistic protection clothing manufacturer CIA Miguel Caballero SAS runs for at least four years.

----------

AIM - LOSERS

----------

Likewise Group PLC, down 18% at 14.90p, 12-month range 13.25p-52.80p. The floor coverings distributor says adjusted pretax profit in 2022 is likely to remain "broadly in line" with that of 2021, when Likewise posted an adjusted pretax profit of GBP1.6 million. Its bottom line has been held back by a high level of investment, as well as poor market conditions that are driving up inflationary pressures.

----------

Greatland Gold PLC, down 5.8% at 8.15p, 12-month range 7.00p-18.40p. The mining development and exploration company reports a "landmark year" but notes its loss widens on rising costs. In the financial year to June 30, Greatland's pretax loss doubles to GBP11.4 million from GBP5.5 million.

----------

IGas Energy PLC, down 0.5% at 27.57p, 12-month range 12.60p-112.00p. IGas says it is "shocked and disappointed" by the UK government's Wednesday decision to declare another moratorium on fracking in England. "Literally a few weeks ago this government lifted the moratorium paving the way for the timely development of shale in the UK providing jobs, tax revenue, energy security and significant community benefits in the middle of an energy crisis - all totally compatible with net zero," IGas says. IGas contends it has significant recoverable gas resource in the Gainsborough Trough in the East Midlands. It warns it may pursue legal action in light of losses it has incurred. Shares are down 30% since Tuesday's close, though they remain up 79% over the past 12 months.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
10 Jun 2024 10:32

AIM WINNERS & LOSERS: Arecor Therapeutics dives on funding needs

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
10 Jun 2024 09:36

Allergy Therapeutics welcomes peanut allergy vaccine trial results

(Alliance News) - Allergy Therapeutics PLC on Monday hailed positive findings from trial results for a peanut allergy vaccine.

Read more
7 May 2024 20:22

TRADING UPDATES: Abingdon Health buys IVDeology Holdings

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Mar 2024 16:13

EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
27 Mar 2024 11:02

AIM WINNERS & LOSERS: Norman Broadbent profit swing on rising revenue

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
12 Mar 2024 14:06

Allergy Therapeutics starts dosing patients in peanut allergy trial

(Alliance News) - Allergy Therapeutics PLC on Tuesday said it has commenced subcutaneous dosing of peanut allergic patients in its phase 1/2a Protect trial.

Read more
1 Mar 2024 15:49

UK shareholder meetings calendar - next 7 days

Monday 4 March 
Ascent Resources PLCGM re bonus issue of preference shares
JPMorgan Emerging Europe, Middle East & Africa Securities PLCAGM
Lexington Gold LtdAGM
Tuesday 5 March 
Ajax Resources PLCGM re extension of investment mandate
Beowulf Mining PLCGM re capital raise
CC Japan Income & Growth Trust PLCAGM
Driver Group PLCAGM
Edinburgh Worldwide Investment Trust PLCAGM
Jersey Electricity PLCAGM
Wednesday 6 March 
Ecofin Global Utilities & Infrastructure Trust PLCAGM
Mila Resources PLCAGM
Paragon Banking Group PLCAGM
Thursday 7 March 
Asia Strategic Holdings LtdAGM
CT UK Capital & Income Investment Trust PLCAGM
Henderson Opportunities Trust PLCAGM
XPS Pensions Group PLCGM re directors' remuneration policy 2024
Friday 8 March 
Allergy Therapeutics PLCAGM
All Things Considered Group PLCAGM
Chenavari Toro Income Fund LtdAGM
Neo Energy Metals PLCAGM
Schroder UK Mid Cap Fund PLCAGM
Silverwood Brands PLCGM re proposed share capital reduction
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
14 Feb 2024 10:22

Allergy Therapeutics forecasts revenue drop but trials going well

(Alliance News) - Allergy Therapeutics PLC on Wednesday said revenue decreased in its latest half year, and expects to require further funding soon.

Read more
5 Feb 2024 14:09

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jan 2024 10:38

Allergy Therapeutics resumes trading on AIM; annual revenue plunges

(Alliance News) - Allergy Therapeutics PLC on Tuesday resumed trading on AIM after the release of its annual results.

Read more
27 Dec 2023 14:17

IN BRIEF: Allergy Therapeutics amends facility, plans warrant issue

Allergy Therapeutics PLC - Sussex-based biotechnology company specialising in allergy vaccines - Shares rise as firm enters amendment to the facility agreement it reached in early April with SkyGem Acquisition Ltd and Southern Fox Investments Ltd. Deal provides Allergy Therapeutics with a GBP40 million secured loan facility of which GBP32.5 million is uncommitted. Facility is available to drawdown between January 15 and the same day in 2026, with interest payable semi-annually at 12% per year and a January 15, 2027 repayment date.

Read more
15 Dec 2023 21:09

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
13 Dec 2023 10:11

Allergy Therapeutics shares jump as hails grass allergy jab data

(Alliance News) - Allergy Therapeutics PLC on Wednesday said that phase-3 trials of its grass allergy injection yielded positive results, moving the product closer to market entry.

Read more
13 Dec 2023 09:55

AIM WINNERS & LOSERS: Impellam climbs on GBP483 million takeover offer

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.